Adenovirus vector ‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins
This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Nicolas Çuburu, Selina Khan, Cynthia D Thompson, Rina Kim, Jort Vellinga, Roland Zahn, Douglas R Lowy, Gert Scheper, John T Schiller Tags: Research Article Source Type: research
More News: Adenoviruses | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Genital Warts | Immunotherapy | Study | Vaccines